Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Can ‘Pact for the Future’ Really Help Reinvigorate UN’s Sustainable Development Pathway? 24/09/2024 Maayan Hoffman Over 130 United Nations member states convened in New York City Sunday and Monday for a long-anticipated Summit of the Future that aimed to press the “reset button” on stalled global development goals and polarized geopolitical debate. The event, held just ahead of the annual debate in the U.N. General Assembly, kicked off with the […] Continue reading -> AI, Conflict Zones, and Crisis Care Take Center Stage at Geneva Cancer Congress 18/09/2024 Maayan Hoffman & Paul Adepoju Geneva, Switzerland—The 2024 World Cancer Congress opened Tuesday in Geneva, bringing together more than 2,000 delegates from more than 120 countries. Its convener said the congress underscores a global commitment to combating the growing burden of cancer. Hosted by the Union for International Cancer Control (UICC), the congress aims to foster collaboration amongst cancer and […] Continue reading -> Africa Can Harness Traditional and Digital Tools to Ensure Better Dementia Care and Treatment 13/09/2024 Maayan Hoffman NAIROBI – Africa can harness community care, traditional health, exercise and digital tools to treat dementia as its population ages, according to experts on the second day of Nature’s “Future of Dementia in Africa” conference,. The conference, the first of its kind in Africa, was presented in conjunction with the Davos Alzheimer’s Collaborative and Aga […] Continue reading -> Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Can ‘Pact for the Future’ Really Help Reinvigorate UN’s Sustainable Development Pathway? 24/09/2024 Maayan Hoffman Over 130 United Nations member states convened in New York City Sunday and Monday for a long-anticipated Summit of the Future that aimed to press the “reset button” on stalled global development goals and polarized geopolitical debate. The event, held just ahead of the annual debate in the U.N. General Assembly, kicked off with the […] Continue reading -> AI, Conflict Zones, and Crisis Care Take Center Stage at Geneva Cancer Congress 18/09/2024 Maayan Hoffman & Paul Adepoju Geneva, Switzerland—The 2024 World Cancer Congress opened Tuesday in Geneva, bringing together more than 2,000 delegates from more than 120 countries. Its convener said the congress underscores a global commitment to combating the growing burden of cancer. Hosted by the Union for International Cancer Control (UICC), the congress aims to foster collaboration amongst cancer and […] Continue reading -> Africa Can Harness Traditional and Digital Tools to Ensure Better Dementia Care and Treatment 13/09/2024 Maayan Hoffman NAIROBI – Africa can harness community care, traditional health, exercise and digital tools to treat dementia as its population ages, according to experts on the second day of Nature’s “Future of Dementia in Africa” conference,. The conference, the first of its kind in Africa, was presented in conjunction with the Davos Alzheimer’s Collaborative and Aga […] Continue reading -> Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Can ‘Pact for the Future’ Really Help Reinvigorate UN’s Sustainable Development Pathway? 24/09/2024 Maayan Hoffman Over 130 United Nations member states convened in New York City Sunday and Monday for a long-anticipated Summit of the Future that aimed to press the “reset button” on stalled global development goals and polarized geopolitical debate. The event, held just ahead of the annual debate in the U.N. General Assembly, kicked off with the […] Continue reading -> AI, Conflict Zones, and Crisis Care Take Center Stage at Geneva Cancer Congress 18/09/2024 Maayan Hoffman & Paul Adepoju Geneva, Switzerland—The 2024 World Cancer Congress opened Tuesday in Geneva, bringing together more than 2,000 delegates from more than 120 countries. Its convener said the congress underscores a global commitment to combating the growing burden of cancer. Hosted by the Union for International Cancer Control (UICC), the congress aims to foster collaboration amongst cancer and […] Continue reading -> Africa Can Harness Traditional and Digital Tools to Ensure Better Dementia Care and Treatment 13/09/2024 Maayan Hoffman NAIROBI – Africa can harness community care, traditional health, exercise and digital tools to treat dementia as its population ages, according to experts on the second day of Nature’s “Future of Dementia in Africa” conference,. The conference, the first of its kind in Africa, was presented in conjunction with the Davos Alzheimer’s Collaborative and Aga […] Continue reading -> Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AI, Conflict Zones, and Crisis Care Take Center Stage at Geneva Cancer Congress 18/09/2024 Maayan Hoffman & Paul Adepoju Geneva, Switzerland—The 2024 World Cancer Congress opened Tuesday in Geneva, bringing together more than 2,000 delegates from more than 120 countries. Its convener said the congress underscores a global commitment to combating the growing burden of cancer. Hosted by the Union for International Cancer Control (UICC), the congress aims to foster collaboration amongst cancer and […] Continue reading -> Africa Can Harness Traditional and Digital Tools to Ensure Better Dementia Care and Treatment 13/09/2024 Maayan Hoffman NAIROBI – Africa can harness community care, traditional health, exercise and digital tools to treat dementia as its population ages, according to experts on the second day of Nature’s “Future of Dementia in Africa” conference,. The conference, the first of its kind in Africa, was presented in conjunction with the Davos Alzheimer’s Collaborative and Aga […] Continue reading -> Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Can Harness Traditional and Digital Tools to Ensure Better Dementia Care and Treatment 13/09/2024 Maayan Hoffman NAIROBI – Africa can harness community care, traditional health, exercise and digital tools to treat dementia as its population ages, according to experts on the second day of Nature’s “Future of Dementia in Africa” conference,. The conference, the first of its kind in Africa, was presented in conjunction with the Davos Alzheimer’s Collaborative and Aga […] Continue reading -> Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Can Africa Lead in Early Detection and Prevention of Dementia? 11/09/2024 Maayan Hoffman NAIROBI, Kenya – Dementia is rapidly becoming a significant public health concern across the globe, with projections estimating 150 million people will be affected by 2050. “Dementia is a health, financial and social problem of almost unimaginable proportions,” said George Vradenburg, founding chairman of the board of the Davos Alzheimer’s Collaborative (DAC). “It may prove […] Continue reading -> From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Human Impact to AI Solutions: Experts To Tackle Cancer’s Challenges in Geneva 04/09/2024 Maayan Hoffman How many children worldwide have been orphaned by the death of their father due to cancer? This is one of the pressing questions researchers will aim to answer and that is a topic amongst the abstracts at this month’s World Cancer Congress. The study, conducted by the France-based International Agency for Research on Cancer (IARC), […] Continue reading -> Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients 08/07/2024 Maayan Hoffman Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading -> Posts navigation Older postsNewer posts